2 Reasons to Watch ELV and 1 to Stay Cautious
1 Healthcare Stock Worth Investigating and 2 That Underwhelm
2 Value Stocks with Exciting Potential and 1 We Avoid
Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.
Why Elevance Health (ELV) Stock Is Trading Up Today
The Republican-led U.S. House voted to advance Democratic legislation that would reinstate enhanced Affordable Care Act health insurance subsidies that expired at the end of 2025, as lawmakers debate competing...
2 Unpopular Stocks That Deserve a Second Chance and 1 We Find Risky
1 Safe-and-Steady Stock with Solid Fundamentals and 2 We Brush Off
Elevance Health is scheduled to release its Q4 results next month, and analysts project a double-digit drop in profit.
Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review...